Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06765551

AI Based Muscular Ultrasound to Assess Intensive Care Unit-acquired Weakness

Conditions: Intensive Care Unit-acquired Weakness, Artifical Intelligence, Ultrasound

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 64
Sponsor: Jena University Hospital

Location: Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital Jena Thuringia

Summary

The aim of this observational case-control study is to investigate, whether artificial intelligence can detect ultrasound-derived imaging characteristics typical for intensive care unit-acquired weakness. The main questions it aims to answer are: 1. Is the evaluation of specific parameters of neuromuscular ultrasound using AI-based image analysis suitable for detecting and monitoring critically ill ICU patients with ICUAW? 2. Do the results of AI-based ultrasound image analysis correlate with: (A) the severity of ICUAW (B) the visual grading of muscle echogenicity (C) the 30- and 90-day-outcome?

Eligibility Criteria

Inclusion Criteria: * Patients aged 18 years or above * Major elective surgery, e.g. cardiothoracic or abdominal surgery * Expected ICU stay \>1 day postoperatively * Healthy, age-machted subjects without ICUAW (recruited from staff of the department of anesthesiology and intensive care medicine) Exclusion Criteria: * No informed consent * Emergency surgery * Previous participation in the same study * Preexisting neuromuscular disease * Preexisting central nervous system disease with residual neuromuscular impairment (e.g. cerebral haemorrhage, stroke, brain tumor) * High-dose glucocorticoid therapy (\>300 mg hydrocortisone or equivalent per day) before or during particiation in the study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06765551). StuddyBuddy aggregates publicly available trial information.